![Biogaia AB Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/sto/biog-b.png?tr=w-200)
Biogaia AB
STO:BIOG B
![Biogaia AB Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/sto/biog-b.png)
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
SE |
![]() |
Biogaia AB
STO:BIOG B
|
12.5B SEK | 11.4 | |
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
297.2B USD | 9.5 | |
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
162.3B USD | 10.8 | |
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.1B USD | 12.9 | |
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
109.6B USD | 9 | |
AU |
![]() |
CSL Ltd
ASX:CSL
|
139.6B AUD | 13.9 | |
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
80.2B USD | 4.7 | |
US |
![]() |
Moderna Inc
NASDAQ:MRNA
|
56.3B USD | 41.8 | |
US |
![]() |
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 24.2 | |
US |
![]() |
Biogen Inc
NASDAQ:BIIB
|
33B USD | 5.3 | |
KR |
![]() |
Celltrion Inc
KRX:068270
|
39.3T KRW | 36.8 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.